A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein

Analytical Biochemistry

Volumn 305, Issue 1, 2002, Pages 106-114

  Garrigues, Alexia ^a   Nugier, Jérôme ^a   Orlowski, Stéphane ^a   Ezan, Eric ^a  

^a DIF   (France)

Author keywords

ATPase; Drug; HTS; P glycoprotein

Indexed keywords

BINDING SITES; CELL CULTURE; CHEMOTHERAPY; GLYCOPROTEINS; MODULATION; SPECTROPHOTOMETRY;

ANTI-CANCER CHEMOTHERAPY; ATPASE; DRUG; HIGH THROUGHPUT SCREENING; MULTIDRUG TRANSPORTERS; MULTIPLE BINDING SITES; P-GLYCOPROTEIN; SPECTRO-PHOTOMETRIC METHOD;

DRUG INTERACTIONS;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; AMILORIDE; AMIODARONE; BROMOCRIPTINE; CAMPTOTHECIN; CHLORPROMAZINE; COLCHICINE; CORTICOSTERONE; CYCLOSPORIN A; DACTINOMYCIN; DEOXYCORTICOSTERONE; DILTIAZEM; DIPYRIDAMOLE; EMETINE; ETOPOSIDE; GLYCOPROTEIN P; IVERMECTIN; MELPHALAN; MIDAZOLAM; MITOXANTRONE; MONENSIN; NICARDIPINE; NIFEDIPINE; PACLITAXEL; PROGESTERONE; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BINDING SITE; CHINESE HAMSTER; DRUG PROTEIN BINDING; ENZYME ACTIVITY; LUNG FIBROBLAST; MEASUREMENT; MEMBRANE VESICLE; MICROTITER PLATE ASSAY; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SCREENING TEST; SPECTROPHOTOMETRY; VALIDATION PROCESS;

CRICETINAE;

EID: 0036605413     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.2002.5650     Document Type: Article

References (33)

1. ABC transporters, from microorganisms to man
2. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
3. Biochemistry of multidrug resistance mediated by the multidrug transporter
4. The P-glycoprotein efflux pump: How does it transport drugs?
5. 3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine
6. 3H]verapamil radioligand-binding assay
7. Photoaffinity substrates for P-glycoprotein
8. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells
9. Saturation reversal of the multidrug pump using many reversers in low-dose combinations
10. Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase
11. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen
12. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer
13. Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein
14. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase: Further experimental evidence for a multisite model
15. Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein
16. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity
17. Effects of steroids and verapamil on P-glycoprotein ATPase activity: Progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators
18. Competitive, nonconpetitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity
19. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents
20. Multiple recognition of various amphiphilic molecules by the multidrug resistance P-glycoprotein: Molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs
21. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, radioautographic, and cytogenetic studies
22. Absence of cooperativity for MgATP and verapamil on the ATPase activity of P-glycoprotein containing membrane vesicles
23. P-glycoprotein substrates and antagonists cluster into two distinct groups
24. 3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: Putative involvement of a P-glycoprotein transporter
25. Cross resistance pattern towards anticancer drugs of a human carcinoma multi-drug-resistant cell line
26. A general pattern for substrate recognition by P-glycoprotein
27. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
28. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells
29. Rational use of in vitro P-glycoprotein assays in drug discovery
30. Structure-activity relationships of P-glycoprotein interacting drugs: Kinetic characterization of their effects on ATPase activity
31. Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements
32. Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity
33. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities